Background/Aims: Angiopoietin-like protein 2 (ANGPTL2) was reported to be implicated in the Methods: ANGPTL2 or TLR4 in streptozotocin (STZ)-induced DN rats and HG-stimulated podocytes. The renal injury index including 24-h proteinuria, blood glucose level, serum creatinine and blood urea nitrogen were measured in DN rats using corresponding commercial kits. The and PTEN expression via western blot. Results: ANGPTL2 and TLR4 were both highly expressed in DN rats compared with control group. ANGPTL2 knockdown alleviated renal injury in STZ-TLR4 expression in both DN rat and cell model. Furthermore, TAK-242 treatment exacerbated accumulation in HG-induced podocytes. Conclusion: ANGPTL2 knockdown ameliorates DN by inhibiting TLR4 expression, an observation contributing to a better understanding of DN pathogenesis.
Introduction
Diabetic nephropathy (DN) is one of the leading microvascular complications in patients with diabetes, affecting approximately 15-25% of type 1 diabetes patients and 30-40% of type 2 diabetes patients [1] . Therefore, it is not surprising that DN is a major endothelial cells and systemic insulin resistance in diet-induced obese mice [8, 9] . ANGPTL2 heart failure and atherosclerosis [8, 10, 11] . ANGPTL2 is highly expressed in the glomeruli from patients with DN but absent in normal glomeruli of control kidney [12] . In addition, upregulation of ANGPTL2 in diabetic glomerulopathy is mainly distributed in podocytes and involved in the progression of diabetic glomerulopathy [12] . However, the biological role of ANGPTL2 and its underlying mechanism in DN remains unclear.
Toll-like receptors (TLRs), important regulators of innate immune system, are abundantly expressed in immune cells, including macrophages, dendritic cells, lymphocytes, and nonimmune cells (such as kidney tubular epithelial cells, endothelial cells and podocytes) [13] . TLRs play a fundamental role in the activation of innate and adaptive immune responses by established that up-regulation of TLR4 is observed in patients with diabetic microvascular disease, particularly in nephropathy, and is related to increased release of various biomediator in endothelial cells and monocytes by a previous study [18] . However, the detailed molecular In our study, we explored the role of ANGPTL2 and its underlying mechanism in DN by establishing streptozotocin (STZ)-induced DN rats as in vivo models of DN and high glucoseinduced podocytes as in vitro models of DN.
Materials and Methods

Animal model and treatment
to 250 g) were purchased from Shanghai Laboratory Animal Center (Shanghai, China). The rats were housed light/dark cycles with free access to normal basal diet and water. Randomly, these rats were divided into four groups (n = 10): control group, DN group, DN + sh-control group and DN + sh-ANGPTL2 group. The rat models of DN were established by intraperitoneally injection of STZ (dissolved in 0.1 M citrate acid buffer, pH equal amount of citric acid buffer. Blood glucose levels were measured on the third day after STZ injection. In addition, the DN rats in DN + sh-ANGPTL2 group or DN + sh-control group received an intravenous injection Biochemical determination th weeks after modeling. Blood samples were collected from the abdominal arota into non-hepatinised tubes, allowed to clot for 2 h well as blood urea nitrogen levels were measured using corresponding commercial assay kits (Jiancheng Biotech, Nanjing, China) following the manual instructions on an automatic biochemical machine (Toshiba USA).
Preparation of primary rat podocytes SD rats were euthanized using an excess amount of pentobarbital (over 50 mg/kg body weight, then cut into 1-2 mm cubes in Hanks' balanced salt solution (HBSS; Invitrogen, Carlsbad, CA, USA), digested glomeruli after magnetic treatment were suspended in a suitable amount of HBSS and then passed through Biotechnology, Santa Cruz, CA, USA) and podoxin (Santa Cruz Biotechnology).
Podocyte culture and treatment
Conditionally immortalized mouse podocytes were cultured in RPMI 1640 medium (Gibco Lab., Grand Island, NY, USA), supplemented with 10% fetal bovine serum (FBS; Gibco Lab.), 100 U/ml penicillin G/ streptomycin, 5.6 mM glucose (Dingguo Changsheng Biotechnology Co., Ltd., Beijing, China) and 10 U/ml with siRNA against ANGPTL2 (si-ANGPTL2) or siRNA negative control (si-NC) using Lipofectamine 2000 (Invitrogen). Subsequently, podocytes were treated with 30 mM D-glucose (high glucose, HG) for 24 h to
Quantitative real-time PCR (qRT-PCR)
Total RNA from kidney cortex and podocytes was isolated using Trizol RNA isolation system (Invitrogen) and reversely transcribed into cDNAs using the SuperScriptTM III First-Strand Synthesis Sequence Detection System (Applied Biosystems Japan, Tokyo, Japan) with SYBR Green Master Mix (Roche Applied Science, Mannheim, Germany) according to the manufacturer's instructions. The PCR program was performed based on the conditions listed below: 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. The PCR results were calculated using the 2 method as described previously [19] and normalized to GAPDH expression. 
Statistical analysis
All data were expressed as mean ± standard deviation (SD) and analyzed using SPSS 16.0 software t-test P < 0.05 was considered statistically
Results
ANGPTL2 and TLR4 were both up-regulated in DN rats
To examine the role of ANGPTL2 and TLR4 in the development of DN, the expressions of ANGPTL2 and TLR4 at mRNA and protein levels in renal tissues of DN rats were analyzed by qRT-PCR and western blot, respectively. The results showed that ANGPTL2 and TLR4 were both highly expressed at mRNA (Fig. 1A) and protein (Fig. 1B ) levels in DN rats when compared to control group. Fig. 1 . Expression levels of ANGPTL2 and TLR4 in DN rats. The expression levels of ANGPTL2 and TLR4 in control rats and DN rats were evaluated by qRT-PCR (A) and western blot (B). The data was expressed as mean ± SD, n =6, *P<0.05. Unpaired ttest was performed. -DN rats were measured by ELISA analysis. The data was expressed as mean ± SD, n =3, *P<0.05. Two-way
ANGPTL2 knockdown alleviated STZ-induced renal damage of DN rats
an intravenous injection of adenovirus carrying sh-ANGPTL2 or shRNA. Firstly, western blot analysis revealed that ANGPTL2 expression was obviously decreased in the sh-ANGPTL2 group, suggesting the successful knockdown of ANGPTL2 ( Fig. 2A) . Moreover, podocyte DN rats, which were partially reversed after ANGPTL2 knockdown ( Fig. 2A) , indicating the involvement of ANGPTL2 in DN. Subsequently, body weight, 24-h proteinuria, blood glucose level, serum creatinine and blood urea nitrogen were measured. The body weight in DN rats was markedly lower than that in control group, while ANGPTL2 knockdown substantially restored body weight compared with sh-NC group in DN rats (P < 0.05) (Fig. 2B ). As displayed in Fig. 2C-2F , the concentrations of 24-h proteinuria, blood glucose level, serum creatinine and blood urea nitrogen were all increased in DN rats compared with control group, whereas these effects were weakened following ANGPTL2 knockdown in contrast to sh-NC group (P < 0.05). Taken together, these data revealed that ANGPTL2 knockdown relieved renal damage of STZ-induced DN rats.
cortex of DN rats by ELISA. The results manifested that the levels of IL-6 ( Fig. 3A and 3E ), ILcortex of DN rats were all increased compared with the control group. By contrast, the compared to sh-NC group in DN rats (P rats.
To investigate the effect of ANGPTL2 knockdown on renal histology of DN, the pathologic characteristics associated with DN in glomeruli were examined in STZ-induced DN rat model. As shown in Fig. 4A , histological examination of kidney sections staining with Masson's On the contrary, ANGPTL2 knockdown markedly inhibited the collagen accumulation and P < 0.05) in DN rats. It was reported that decreased expression of PTEN in mesangial cells contributed to expansion of the mesangial matrix [20] . Thus, PTEN expression in DN rats was determined to evaluate the accumulation of ECM. As displayed in was down-regulated in DN rats compared with control group, while ANGPTL2 knockdown dramatically reversed these effects (P < 0.05), indicating that ANGPTL2 knockdown abated glomerular section was decreased in DN rats compared with control group, while ANGPTL2 group (P < 0.05) (Fig. 4C) , suggesting that ANGPTL2 knockdown was able to prevent podocyte podocytes, and HG-stimulated podocytes transfected with si-ANGPTL2 or si-NC. The data was expressed as 
ANGPTL2 knockdown inhibited TLR4 expression level in STZ-induced DN rats
In order to explore the effect of ANGPTL2 on TLR4, the expression level of TLR4 at mRNA and protein levels in DN rats injected with sh-ANGPTL2 or sh-NC was evaluated by qRT-PCR and western blot, respectively. As presented in Fig. 5A and 5B, the mRNA and protein levels of TLR4 in DN rats were both higher than that in control group, however, this effect P < 0.05). All these data suggested that ANGPTL2 knockdown restrained TLR4 expression at mRNA and protein levels in STZinduced DN rats.
to HG condition
The cell models of DN were established by treating podocytes with high glucose (30 mM) conditions. However, siRNA-mediated ANGPTL2 knockdown led to an obvious suppression podocytes.
To verify the effect of ANGPTL2 knockdown on ECM accumulation in vitro, the protein As expected, ANGPTL2 knockdown by si-ANGPTL2 dramatically counteracted these effects. These results indicated that ANGPTL2 knockdown diminished HG-induced ECM accumulation in podocytes.
ANGPTL2 knockdown inhibited TLR4 expression in podocytes exposed to HG conditions
The impact of ANGPTL2 knockdown on the expression level of TLR4 at mRNA and and western blot results disclosed that HG treatment strikingly promoted the expression of TLR4 at mRNA (Fig. 8A ) and protein ( Fig. 8B ) levels in podocytes, but this effect was greatly abrogated after down-regulating ANGPTL2 by si-ANGPTL2 in HG-induced podocytes, protein levels in podocytes.
by inhibiting TLR4 in HG-induced podocytes mechanism ANGPTL2 involved in podocytes under HG conditions. As demonstrated by qRT- podocytes. Mechanistic studies revealed that ANGPTL2 knockdown exerted its protective effect on DN by inhibiting TLR4 expression in vitro, contributing to a better understanding of the pathogenetic mechanism of DN and providing potential therapeutic target for DN. However, the molecular correlation between ANGPTL2 and TLR4 suggested in the in vivo model of DN still need further investigation.
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